Algert Global LLC Olema Pharmaceuticals, Inc. Transaction History

Algert Global LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$10.95 - $16.62 $367,701 - $558,099	33,580 New	33,580 $380,000
Q3 2023 Nov 13, 2023	SELL	$8.19 - $12.98 $85,667 - $135,770	-10,460 Reduced 18.01%	47,630 $588,000
Q2 2023 Aug 14, 2023	BUY	$3.22 - $9.65 $146,960 - $440,426	45,640 Added 366.59%	58,090 $525,000
Q1 2023 May 12, 2023	SELL	$2.55 - $4.97 $24,964 - $48,656	-9,790 Reduced 44.02%	12,450 $43,000
Q3 2022 Nov 15, 2022	BUY	$2.72 - $5.88 $60,492 - $130,771	22,240 New	22,240 $61,000

136

58.7M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $227M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.